Icons / Logo / Facebook Created with Sketch. Icons / Logo / Google Created with Sketch. Icons / Logo / ORCID Created with Sketch. Branding/Logomark minus Citation Combined Shape Icon/Bookmark-empty Icon/Copy Icon/Collection Icon/Close Copy 7 no author result Created with Sketch. Icon/Back Created with Sketch. Match!
Richard A. Watts
University of East Anglia
340Publications
49H-index
10.5kCitations
Publications 340
Newest
Published in Arthritis Care and Research 4.53
K. Bates Gribbons1
Estimated H-index: 1
(NIH: National Institutes of Health),
Cristina Ponte7
Estimated H-index: 7
+ -3 AuthorsKathleen Maksimowicz-McKinnon20
Estimated H-index: 20
(HFHS: Henry Ford Health System)
Published on Jul 19, 2019in Rheumatology 5.15
Max Yates7
Estimated H-index: 7
(UEA: University of East Anglia),
Robert Luben95
Estimated H-index: 95
(University of Cambridge)
+ 5 AuthorsAlex J. MacGregor57
Estimated H-index: 57
(UEA: University of East Anglia)
Published on Jul 3, 2019in Annals of the Rheumatic Diseases 14.30
Bernhard Hellmich35
Estimated H-index: 35
(University of Tübingen),
Ana Águeda2
Estimated H-index: 2
+ 23 AuthorsChristian Dejaco24
Estimated H-index: 24
(University of Graz)
Background Since the publication of the European League Against Rheumatism (EULAR) recommendations for the management of large vessel vasculitis (LVV) in 2009, several relevant randomised clinical trials and cohort analyses have been published, which have the potential to change clinical care and therefore supporting the need to update the original recommendations. Methods Using EULAR standardised operating procedures for EULAR-endorsed recommendations, the EULAR task force undertook a systemati...
Published on Nov 12, 2018in Rheumatology 5.15
F. Coath1
Estimated H-index: 1
,
Kate Gillbert1
Estimated H-index: 1
+ 13 AuthorsJohn R. Mills8
Estimated H-index: 8
Published on Jun 1, 2019in Annals of the Rheumatic Diseases 14.30
Keziah Austin (University Hospitals Bristol NHS Foundation Trust), Emma Dures13
Estimated H-index: 13
(University of the West of England)
+ 8 AuthorsRichard A. Watts49
Estimated H-index: 49
(UEA: University of East Anglia)
Background Giant cell arteritis (GCA) is the most common vasculitis in the UK, with an incidence of 220 cases/million in adults over 50 years of age. The physical symptoms as well as the side effects of glucocorticoids may impact patients’ ability to exercise. Maintaining physical activity (PA) has been shown to be beneficial to disease activity in other inflammatory conditions, and is also a specific priority for GCA patients. Objectives To explore patient perceptions of physical activity in GC...
Published on Jun 1, 2019in Annals of the Rheumatic Diseases 14.30
Max Yates7
Estimated H-index: 7
(UEA: University of East Anglia),
Tunde Peto28
Estimated H-index: 28
('QUB': Queen's University Belfast)
+ 12 AuthorsRobert Luben95
Estimated H-index: 95
(University of Cambridge)
Background Vascular risk factors are implicated in the aetiology of polymyalgia rheumatica (PMR) but lack sensitivity as a screening tool to assess risk of future disease or disease progression. Retinal vascular measures from digital images of the retinal fundus provide a direct objective measure of vascular health and have potential value in estimating future disease risk. Objectives The aim of this study was to determine if quantitative changes on retinal vasculometric imaging could be detecte...
Published on May 1, 2019in Annals of the Rheumatic Diseases 14.30
Max Yates7
Estimated H-index: 7
,
Jalpa Kotecha (UEA: University of East Anglia)+ 3 AuthorsAlex J. MacGregor57
Estimated H-index: 57
The relationship between polymyalgia rheumatica (PMR) and inflammatory polyarthritis (IP) remains a source of debate in rheumatology: although both conditions have been classified separately as distinct entities, they share many clinical features.1–4 It remains unclear whether synovitis in IP is part of a spectrum of PMR, or if the symptoms of PMR are early manifestations of a distinct diagnosis of IP. Alternatively, the arthritis that develops in PMR might represent a phenotypic transformation ...
Published on Apr 1, 2019in BMJ Open 2.38
Venkatesan Thiruvenkatarajan6
Estimated H-index: 6
,
Jenn Yuan Lee (University of Adelaide)+ 2 AuthorsRoelof Markus Van Wijk3
Estimated H-index: 3
Introduction and aims Esmolol is an ultra-short-acting β 1 antagonist that has been shown to attenuate the corrected QT (QTc) interval prolongation associated with laryngoscopy and endotracheal intubation (LTI). Prolongation of the QTc interval can precipitate arrhythmias, the most serious of which is torsades de pointes . The aim of this systematic review was to compare esmolol and placebo on QTc changes occurring during LTI. Materials and methods PubMed, EMBASE, Cochrane Registry of Clinical T...
Published on Mar 1, 2019in Rheumatology 5.15
Katherine Gribbons (NIH: National Institutes of Health), Cristina Ponte7
Estimated H-index: 7
+ 22 AuthorsKathleen Maksimowicz-McKinnon20
Estimated H-index: 20
(HFHS: Henry Ford Health System)
Published on Mar 1, 2019in Rheumatology 5.15
Cristina Ponte7
Estimated H-index: 7
,
Peter C. Grayson14
Estimated H-index: 14
+ 9 AuthorsRichard A. Watts49
Estimated H-index: 49
(UEA: University of East Anglia)
12345678910